<DOC>
	<DOCNO>NCT00533962</DOCNO>
	<brief_summary>Introduction : Ocular administration glucocorticoid common effective treatment several ocular disease . However often complicate elevation intraocular pressure ( IOP ) . Anecortave acetate ( AA ) analog cortisol acetate lack typical anti-inflammatory immunosuppressive property glucocorticoid . The effect anterior juxtascleral depot ( AJD ) injection evaluate case glaucoma cause intravitreal triamcinolone acetonide , present impressive result . The purpose study evaluate efficacy safety AA injection possible antiglaucoma treatment alternative . Methods : A prospective clinical study carry include 30 glaucoma patient ( 30 eye ) . After inclusion patient receive single AJD injection 30 mg AA select eye . Main outcome measure include : intraocular pressure 1st day , 7th day , 1st , 2nd 3rd month .</brief_summary>
	<brief_title>IOP Reduction After Anecortave Acetate Injection Glaucoma Patients</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Anecortave</mesh_term>
	<criteria>Advanced glaucoma case surgery cyclophotocoagulation indication ( IOP 25 mmHg ) Patients maximum tolerated medication Low best correct visual acuity ( bad 20/100 ) Under 18 80</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>Glaucoma</keyword>
	<keyword>Anecortave Acetate</keyword>
	<keyword>Intraocular pressure</keyword>
	<keyword>Advanced glaucoma case uncontrolled IOP</keyword>
</DOC>